Title:
抗CD47抗体及びその使用
Document Type and Number:
Japanese Patent JP7262440
Kind Code:
B2
Abstract:
Anti-CD47 antibodies and antigen-binding fragments thereof are described. Also described are nucleic acids encoding the antibodies, compositions comprising the antibodies, and methods of producing the antibodies and using the antibodies for treating or preventing diseases such as cancer, inflammatory disease, infectious disease, atherosclerosis, cardiovascular disease, metabolic disease, radiation-induced injury, and/or autoimmune disease.
More Like This:
Inventors:
One, Mingan
Elephant, Hui
Oaks, Joshua
Jia, Hai Chun
Elephant, Hui
Oaks, Joshua
Jia, Hai Chun
Application Number:
JP2020505360A
Publication Date:
April 21, 2023
Filing Date:
July 30, 2018
Export Citation:
Assignee:
Faines Therapeutics, Incorporated
International Classes:
C12N15/13; A61K39/395; A61P3/00; A61P9/00; A61P9/10; A61P29/00; A61P31/04; A61P35/00; A61P37/02; C07K16/28; C07K16/46; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/63; C12P21/08; G01N33/53; G01N33/531
Domestic Patent References:
JP2016507555A | ||||
JP2015536351A | ||||
JP2015508072A | ||||
JP2011519345A |
Foreign References:
WO2017121771A1 | ||||
WO2017053423A1 | ||||
WO2017049251A2 | ||||
WO2016109415A1 | ||||
WO2016081423A1 | ||||
CN106084052A |
Attorney, Agent or Firm:
Patent Attorney Corporation Hiraki International Patent Office